Life Sciences & Health Care
Life Sciences Insights.
Research and analysis on pharmaceuticals, biotech, medtech, and health systems.
Featured insights
Innovation under scrutiny.
Life sciences and healthcare operate where sensitive data, cross-border deals and rising disclosure standards meet. Our latest thinking for the sector.
Risk & Regulatory
Data Privacy & Cross-Border Transfers: 2026 Update
Health and genomic data are among the most regulated categories — and the most exposed in global research.
Read insight →Legal & M&A
Cross-Border M&A: The 2026 Regulatory Landscape
Biotech and medtech deals increasingly face national-security and critical-technology review.
Read insight →ESG & Assurance
ESG Beyond Compliance: Global Standards for 2026
Access, supply-chain ethics and environmental impact are now reported and assured, not just asserted.
Read insight →